New trial may revolutionise treatment of spinal cord injury patients

Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries. In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage. Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries. In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage. Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries. In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage. Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries. In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage. Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries. In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage. Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries. In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage. Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries. In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage. Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries. In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage.